Seoul stocks exceed 2,200-level for first time in five months on COVID-19 vaccine hopes
Jul 15, 2020
The South Korean benchmark stock index finished above the 2,200-level for the first time in nearly five months on Wednesday, largely on hopes for a coronavirus vaccine and economic recovery. The Korean won rose against the US dollar. The Korea Composite Stock Price Index (KOSPI) rose 18.27 points, or 0.84 percent, to close at 2,201.88. The index surpassed 2,200 for the first time since 2,210.34 on Feb. 19. Trading volume was high at about 811 million shares worth some 13.4 trillion won ($11.